Circular RNAs in endometrial carcinoma (Review)

Oncol Rep. 2022 Dec;48(6):212. doi: 10.3892/or.2022.8427. Epub 2022 Oct 20.

Abstract

As one of the leading causes of death in women in Western developed countries, endometrial carcinoma (EC) is a common gynecological malignant tumor that seriously threatens women's health. In recent years, a trend has emerged of EC being manifested in younger women, and its overall incidence is gradually rising. Circular RNAs (circRNAs) are novel endogenous transcripts that have limited ability to encode proteins due to their covalent closed‑loop structure, which differs from that of other types of RNA. A growing body of evidence has demonstrated that circRNAs fulfill an important role in lung cancer, gastric cancer, breast cancer, EC and other malignant tumor types, and they can affect the occurrence and development of these malignancies through a variety of pathways, further demonstrating the potential of circRNAs as molecular biomarkers for the diagnosis, treatment and prognosis of malignant tumors. The purpose of the present review is to summarize the current understanding of the biogenesis and effects of circRNAs, and to discuss the expression, function and underlying mechanism of circRNAs in EC in order to identify potential novel biomarkers.

Keywords: circular RNAs; endometrial carcinoma; epigenetic regulation; microRNAs; oncogenesis.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Endometrial Neoplasms* / genetics
  • Female
  • Humans
  • RNA / genetics
  • RNA, Circular / genetics
  • Stomach Neoplasms* / genetics

Substances

  • RNA, Circular
  • RNA
  • Biomarkers

Grants and funding

The present study was supported by a grant from The National Natural Science Foundation of China (grant no. 81972522) and Shenyang Medical College postgraduate Science and Technology Innovation Fund Project (grant no. Y20210520).